Preventing a second stroke
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Having had one stroke is the strongest predictor of having another, and the risk is highest in the weeks immediately afterwards.
It is also the point at which prevention is most effective, because the cause is now known and can be targeted specifically.
Related pages: Stroke
The bottom line
- Around a quarter of strokes occur in people who have had a previous stroke or TIA.
- Antiplatelet treatment is standard after an ischemic stroke not caused by atrial fibrillation.
- Anticoagulation is far more effective than antiplatelets where atrial fibrillation is the cause.
- Statins reduce recurrence regardless of starting cholesterol in most cases.
- Blood pressure control is the single largest long-term lever.
- The optimal duration of dual antiplatelet therapy.
- Who benefits from closing a patent foramen ovale.
- When to restart anticoagulation after a bleed.
The story, step by step
- 1. Matching the cause ()
- 2. Antiplatelets ()
- 3. Atrial fibrillation ()
- 4. The rest of the regimen ()
- 5. Procedures ()
What the evidence labels mean
Why it is not one pill
What happens
Different causes, different prevention.
What the research shows
- A clot from a fibrillating heart needs an anticoagulant. Antiplatelets are substantially less effective for this and are not an adequate substitute.
- A clot from a narrowed carotid artery may need surgery or a stent, plus antiplatelets and a statin.
- Small vessel disease needs blood pressure and diabetes control above all.
- A tear in an artery wall is usually treated with antithrombotic medication for a period while it heals.
- A bleed needs blood pressure control, and the question of whether any blood thinner can be used at all.
- This is why the workup matters: giving everyone aspirin would leave a large group substantially under-protected.
Why it matters
Aspirin for a stroke caused by atrial fibrillation is one of the clearest examples of the right drug for the wrong mechanism.
What's still uncertain
- How often the cause is mis-assigned.
- How much prolonged monitoring changes treatment.
Read more
- American Heart Association / American Stroke AssociationNonprofit
- NHLBI: Atrial fibrillationGovernment
- MedlinePlus: Blood thinnersGovernment
Next: Antiplatelets
Aspirin and the others
What happens
For most ischemic strokes.
What the research shows
- Aspirin, clopidogrel, or aspirin combined with dipyridamole are the standard options after an ischemic stroke not caused by atrial fibrillation.
- For minor strokes and high-risk TIAs, a short course of aspirin plus clopidogrel together, typically 21 to 90 days, reduces early recurrence, followed by a single agent long term.
- Longer dual therapy increases bleeding without adding benefit, so the limited duration is deliberate.
- Some people have a genetic variation that makes clopidogrel less effective, and testing is used in some settings.
- The main risk is bleeding, particularly from the stomach. A stomach-protecting drug is sometimes added.
- These are preventive medicines, taken indefinitely, and stopping them raises risk. Any planned interruption for surgery or dental work should be discussed rather than decided alone.
Why it matters
Stopping an antiplatelet before a procedure without asking is a recognised cause of recurrent stroke, and it is easy to do unknowingly.
What's still uncertain
- The optimal duration of dual antiplatelet therapy.
- Whether genotype-guided choice improves outcomes.
Read more
- MedlinePlus: Blood thinnersGovernment
- American Heart Association / American Stroke AssociationNonprofit
- MedlinePlus: Ischemic strokeGovernment
Next: Atrial fibrillation
Anticoagulation
What happens
A different and much larger benefit.
What the research shows
- Atrial fibrillation causes blood to pool in the left atrium, where clots form and can travel to the brain. These strokes tend to be large.
- Anticoagulation reduces that risk by around two thirds, far more than antiplatelet treatment does.
- Direct oral anticoagulants have largely replaced warfarin for most people: no regular blood tests, fewer food interactions and less intracranial bleeding.
- Warfarin remains necessary for mechanical heart valves and some other situations.
- The main risk is bleeding, and the decision weighs stroke risk against bleeding risk using scoring systems, though for most people with atrial fibrillation and a prior stroke the balance clearly favours treatment.
- For those who genuinely cannot take anticoagulants, a device can be placed to close off the left atrial appendage where most clots form.
Why it matters
Under-treatment of atrial fibrillation remains one of the largest preventable causes of severe stroke, often from fear of bleeding that the arithmetic does not support.
What's still uncertain
- How to improve anticoagulation rates in older patients.
- Who benefits most from appendage closure.
Read more
- NHLBI: Atrial fibrillationGovernment
- MedlinePlus: Blood thinnersGovernment
- American Heart Association / American Stroke AssociationNonprofit
Next: The rest of the regimen
Statins, pressure, sugar
What happens
The unglamorous majority of the benefit.
What the research shows
- A statin is started after most ischemic strokes, often at high intensity, and reduces recurrence even in people whose cholesterol was not high.
- Blood pressure control is the single largest lever. Lowering it after a stroke substantially reduces recurrence, and the target is usually below 130/80.
- Treatment is normally started or intensified in the days after the acute phase rather than immediately, because blood pressure often settles on its own.
- Diabetes control matters, and some diabetes medicines have specific cardiovascular benefit.
- Stopping smoking roughly halves the excess risk within a few years.
- Weight, activity, alcohol, sleep apnea and diet all contribute, and a Mediterranean-style pattern has trial evidence for reducing stroke.
Why it matters
Blood pressure does more work here than any antiplatelet, and it is the thing most likely to drift untreated once the acute phase is over.
What's still uncertain
- The optimal blood pressure target after stroke.
- How best to sustain risk factor control long term.
Read more
- CDC: High blood pressureGovernment
- CDC: Preventing strokeGovernment
- NHLBI: Heart-healthy livingGovernment
Next: Procedures
Carotid, PFO and the rest
What happens
For specific findings.
What the research shows
- A carotid artery narrowed by 50 to 99 percent on the side that caused the stroke may be treated by surgery to remove the plaque, or by stenting.
- The benefit is greatest when done within two weeks of the stroke or TIA, and falls off considerably after that, which is why urgency matters.
- Surgery carries a small risk of causing a stroke itself, so it is offered where the arithmetic favours it.
- Narrowing found incidentally without symptoms is usually treated with medicines rather than surgery.
- A patent foramen ovale, a hole between the upper heart chambers, is present in about a quarter of people. Closing it reduces recurrence in carefully selected younger patients with no other explanation for their stroke.
- Most people with a PFO and a stroke do not need it closed, and selection is specialist work.
Why it matters
The two-week window for carotid surgery is the detail most often lost, and a delay converts an effective operation into a marginal one.
What's still uncertain
- How to reduce delays to carotid intervention.
- Better selection criteria for PFO closure.